A critical breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This vital cancer inhibitor protein is frequently inactivated in several kinds of tumors, leading https://bookmark-search.com/story21817540/nanobodies-reactivate-the-p53-protein-a-new-hope-for-malignant-treatment